×
The Standard e-Paper
Fearless, Trusted News
The Standard Group Plc is a
multi-media organization with investments in media platforms spanning newspaper
print operations, television, radio broadcasting, digital and online services. The
Standard Group is recognized as a leading multi-media house in Kenya with a key
influence in matters of national and international interest.
An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP. [Reuters]
Rival antiviral pills from Pfizer Inc and Merck & Co that demonstrated efficacy in trials of adults with Covid-19 who are at high risk of serious illness are now both in use. The drugs are being studied to see if they can prevent infection in people exposed to the virus.
Subscribe to our newsletter and stay updated on the latest developments and special offers!
join